Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hunninghake, DB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 76 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Walenga, JM; Hoppensteadt, D; Pifarre, R; Fox, NL; Forman, S; Hunninghake, DB; Campeau, L; Herd, JA; Hoogwerf, BJ; Hickey, A; Probstfield, JL; Terrin, ML
      The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    2. Illingworth, RD; Crouse, JR; Hunninghake, DB; Davidson, MH; Escobar, ID; Stalenhoef, AFH; Paragh, G; Ma, PTS; Liu, M; Melino, MR; O'Grady, L; Mercuri, M; Mitchel, YB
      A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial

      CURRENT MEDICAL RESEARCH AND OPINION
    3. Hirsch, AT; Criqui, MH; Treat-Jacobson, D; Regensteiner, JG; Creager, MA; Olin, JW; Krook, SH; Hunninghake, DB; Comerota, AJ; Walsh, ME; McDermott, MM; Hiatt, WR
      Peripheral arterial disease detection, awareness, and treatment in primarycare

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    4. Cleeman, JI; Grundy, SM; Becker, D; Clark, LT; Cooper, RS; Denke, MA; Howard, WJ; Hunninghake, DB; Illingworth, DR; Luepker, RV; McBride, P; McKenney, JM; Pasternak, RC; Stone, NJ; Van Horn, L; Brewer, HB; Ernst, ND; Gordon, D; Levy, D; Rifkind, B; Rossouw, JE; Savage, P; Haffner, SM; Orloff, DG; Proschan, MA; Schwartz, JS; Sempos, CT; Shero, ST; Murray, EZ
      Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    5. Dujovne, CA; Bays, H; Davidson, MH; Knopp, R; Hunninghake, DB; Stein, EA; Goldberg, AC; Jones, P; Lipka, LJ; Cuffie-Jackson, C
      Reduction of LDL cholesterol in patients with primary hypercholesterolemiaby SCH 48461: Results of a multicenter dose-ranging study

      JOURNAL OF CLINICAL PHARMACOLOGY
    6. Aras, O; Tsai, MY; Hanson, NQ; Bailey, R; Rao, GD; Hunninghake, DB
      Cystatin C is an independent predictor of fasting and post-methionine loadtotal homocysteine concentrations among stable renal transplant recipients

      CLINICAL CHEMISTRY
    7. White, CW; Gobel, FL; Campeau, L; Knatterud, GL; Forman, SA; Forrester, JS; Geller, NL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hunninghake, DB; Rosenberg, Y; Terrin, ML
      Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the Post CoronaryArtery Bypass Graft Trial

      CIRCULATION
    8. Pitt, B; Byington, RP; Furberg, CD; Miller, ME; Riley, W; Hunninghake, DB; Mancini, GBJ
      Does amlodipine increase cancer incidence? Response

      CIRCULATION
    9. Pitt, B; Byington, RP; Furberg, CD; Hunninghake, DB; Mancini, GBJ; Miller, ME; Riley, W
      Confusing press releases and the PREVENT study - Response

      CIRCULATION
    10. Simon, JA; Hunninghake, DB; Agarwal, SK; Lin, F; Cauley, JA; Ireland, CC; Pickar, JH
      Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease - The heart and estrogen/progestin replacement study

      ANNALS OF INTERNAL MEDICINE
    11. Hunninghake, DB
      Postdischarge lipid management of coronary artery disease patients according to the new National Cholesterol Education Program guidelines

      AMERICAN JOURNAL OF CARDIOLOGY
    12. Popma, JJ; Hunninghake, DB; Arad, Y; Blumenthal, RS; Boden, WE; Selwyn, AP
      Roundtable discussion: Therapeutic challenges and deficiencies

      AMERICAN JOURNAL OF CARDIOLOGY
    13. White, CW; Campeau, L; Canner, P; Domanski, M; Forrester, JS; Gobel, FL; Herd, JA; Hoogwerf, BJ; Hunninghake, DB; Knatterud, GL; LoPresti, F
      Lessons from the Post Coronary Artery Bypass Graft study in evaluating andcontrolling technical variability in angiographic trials

      AMERICAN JOURNAL OF CARDIOLOGY
    14. Hunninghake, DB; McKenney, JM
      Introduction: Missing the target with lipid-lowering therapy

      AMERICAN JOURNAL OF MANAGED CARE
    15. Hunninghake, DB; McKenney, JM; Gotto, AM; Mehta, JL; Jones, PH
      Achieving more aggressive low-density lipoprotein cholesterol lowering

      AMERICAN JOURNAL OF MANAGED CARE
    16. Buchwald, H; Menchaca, HJ; Michalek, VN; Rohde, TD; Hunninghake, DB; O'Dea, TJ
      Plasma cholesterol: An influencing factor in red blood cell oxygen releaseand cellular oxygen availability

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    17. Davidson, MH; Stein, EA; Hunninghake, DB; Ose, L; Dujovne, CA; Insull, W; Bertolami, M; Weiss, SR; Kastelein, JJP; Scott, RS; Campodonico, S; Escobar, ID; Schrott, HG; Bays, H; Stepanavage, ME; Wu, M; Tate, AC; Melino, MR; Kush, D; Mercuri, M; Mitchel, YB
      Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    18. Hunninghake, DB; Maki, KC; Kwiterovich, PO; Davidson, MH; Dicklin, MR; Kafonek, SD
      Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: A long-term, randomized clinical trial in free-living persons with hypercholesterolemia

      JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
    19. Ose, L; Davidson, MH; Stein, EA; Kastelein, JJP; Scott, RS; Hunninghake, DB; Campodonico, S; Insull, W; Escobar, ID; Schrott, HG; Stepanavage, ME; Wu, M; Tate, AC; Melino, MR; Mercuri, M; Mitchel, YB
      Lipid-altering efficacy and safety of simvastatin 80 mg/day: Long-term experience in a large group of patients with hypercholesterolemia

      CLINICAL CARDIOLOGY
    20. Elam, MB; Hunninghake, DB; Davis, KB; Garg, R; Johnson, C; Egan, D; Kostis, JB; Sheps, DS; Brinton, EA
      Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease - The ADMIT Study: A randomized trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    21. Knatterud, GL; Rosenberg, Y; Campeau, L; Geller, NL; Hunninghake, DB; Forman, SA; Forrester, JS; Gobel, FL; Herd, JA; Hickey, A; Hoogwerf, BJ; Terrin, ML; White, C
      Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial

      CIRCULATION
    22. Pitt, B; Byington, RP; Furberg, CD; Hunninghake, DB; Mancini, GBJ; Miller, ME; Riley, W
      Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events

      CIRCULATION
    23. Kastelein, JJP; Isaacsohn, JL; Ose, L; Hunninghake, DB; Frohlich, J; Davidson, MH; Habib, R; Dujovne, CA; Crouse, JR; Liu, MZ; Melino, MR; O'Grady, L; Mercuri, M; Mitchel, YB
      Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

      AMERICAN JOURNAL OF CARDIOLOGY
    24. Garg, R; Elam, MB; Crouse, JR; Davis, KB; Kennedy, JW; Egan, D; Herd, JA; Hunninghake, DB; Johnson, WC; Kostis, JB; Sheps, DS; Applegate, WB
      Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease

      AMERICAN HEART JOURNAL
    25. Walenga, JM; Hoppensteadt, D; Pifarre, R; Cressman, MD; Hunninghake, DB; Fox, NL; Terrin, ML; Probstfield, JL
      Hemostatic effects of 1 mg daily warfarin on post CABG patients

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    26. Hunninghake, DB
      Pharmacologic management of triglycerides

      CLINICAL CARDIOLOGY
    27. Hoogwerf, BJ; Waness, A; Cressman, M; Canner, J; Campeau, L; Domanski, M; Geller, N; Herd, A; Hickey, A; Hunninghake, DB; Knatterud, GL; White, C
      Effects of aggressive cholesterol lowering and low-dose anticoagulation onclinical and angiographic outcomes in patients with diabetes - The post coronary artery bypass graft trial

      DIABETES
    28. Campeau, L; Hunninghake, DB; Knatterud, GL; White, CW; Domanski, M; Forman, SA; Forrester, JS; Geller, NL; Gobel, FL; Herd, JA; Hoogwerf, BJ; Rosenberg, Y
      Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors - NHLBI post coronary artery bypass graft clinical trial

      CIRCULATION
    29. Byington, RP; Evans, GW; Espeland, MA; Applegate, WB; Hunninghake, DB; Probstfield, J; Furberg, CD
      Effects of lovastatin and warfarin on early carotid atherosclerosis - Sex-specific analyses

      CIRCULATION
    30. Egan, DA; Garg, R; Wilt, TJ; Pettinger, MB; Davis, KB; Crouse, J; Herd, JA; Hunninghake, DB; Sheps, DS; Kostis, JB; Probstfield, J; Waclawiw, MA; Applegate, W; Elam, MB
      Rationale and design of the arterial disease multiple intervention trial (ADMIT) pilot study

      AMERICAN JOURNAL OF CARDIOLOGY
    31. Hunninghake, DB
      Bile-acid sequestering agents (resins)

      LIPOPROTEINS IN HEALTH AND DISEASE
    32. KOREN MJ; SMITH DG; HUNNINGHAKE DB; DAVIDSON MH; MCKENNEY JM; WEISS SR; SCHROTT HG; HENLEY RW; TRESH P; MCLAIN RW; BAKKERARKEMA RG; BLACK DM
      THE COST OF REACHING NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) GOALS IN HYPERCHOLESTEROLEMIC PATIENTS - A COMPARISON OF ATORVASTATIN, SIMVASTATIN, LOVASTATIN AND FLUVASTATIN

      PharmacoEconomics
    33. Elam, MB; Heckman, J; Crouse, JR; Hunninghake, DB; Herd, JA; Davidson, M; Gordon, IL; Bortey, EB; Forbes, WP
      Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    34. SIMON JA; GRADY D; SNABES MC; FONG J; HUNNINGHAKE DB
      ASCORBIC-ACID SUPPLEMENT USE AND THE PREVALENCE OF GALLBLADDER-DISEASE

      Journal of clinical epidemiology
    35. CAMPEAU L; KNATTERUD G; DOMANSKI M; FORRESTER JS; GELLER N; GOBEL F; HERD JA; HOOGWERF B; HUNNINGHAKE DB; WHITE C; ROSENBERG Y
      DELAYED PROGRESSION OF ATHEROSCLEROSIS IN CORONARY-BYPASS GRAFTS IS SIMILAR IN WOMEN COMPARED TO MEN FOLLOWING AGGRESSIVE CHOLESTEROL-LOWERING DESPITE MORE FREQUENT RISK-FACTORS - POST CABG TRIAL

      Journal of the American College of Cardiology
    36. Wu, GP; Yuan, J; Hunninghake, DB
      Effect of human apolipoprotein E isoforms on plasma lipids, lipoproteins and apolipoproteins in apolipoprotein E-deficient mice

      ATHEROSCLEROSIS
    37. HUNNINGHAKE DB
      CLINICAL EFFICACY OF CERIVASTATIN - PHASE IIA DOSE-RANGING AND DOSE-SCHEDULING STUDIES

      The American journal of cardiology
    38. DAVIGNON J; HANEFELD M; NAKAYA N; HUNNINGHAKE DB; INSULL W; OSE L
      CLINICAL EFFICACY AND SAFETY OF CERIVASTATIN - SUMMARY OF PIVOTAL PHASE IIB III STUDIES/

      The American journal of cardiology
    39. Hunninghake, DB
      Is aggressive cholesterol control justified? Review of the post-coronary artery bypass graft trial

      AMERICAN JOURNAL OF CARDIOLOGY
    40. HUNNINGHAKE DB
      REVIEW OF THE NIH POST-CABG STUDY AND FUTURE ADVANCES IN HMG-COA THERAPY

      American journal of managed care
    41. ELAM MB; HECKMAN J; CROUSE JR; HUNNINGHAKE DB; HERD JA; DAVIDSON M; FORBES W
      EFFECT OF CILOSTAZOL ON PLASMA-LIPOPROTEINS IN PATIENTS WITH INTERMITTENT CLAUDICATION

      Journal of the American College of Cardiology
    42. HAINER JW; HUNNINGHAKE DB; BENEDEK IH; BROYLES FE; GARNER DM; JENKINS RM; MCGINN A; PIENIASZEK HJ; LONDON E; GILLIES PJ
      DMP-504, A NOVEL HYDROGEL BILE-ACID SEQUESTRANT - III - SAFETY, TOLERABILITY, AND CHOLESTEROL-LOWERING IN HEALTHY HYPERCHOLESTEROLEMIC SUBJECTS

      Drug development research
    43. LOVATO LC; HILL K; HERTERT S; HUNNINGHAKE DB; PROBSTFIELD JL
      RECRUITMENT FOR CONTROLLED CLINICAL-TRIALS - LITERATURE SUMMARY AND ANNOTATED-BIBLIOGRAPHY

      Controlled clinical trials
    44. CAMPEAU L; KNATTERUD GLMK; DOMANSKI M; HUNNINGHAKE DB; WHITE CW; GELLER NL; ROSENBERG Y; HERD A; COCANOUGHER MK; DUNN K; FARMER J; FOREYT J; GREGORY K; INSULL W; JACKSON M; KLEIMAN N; LEWIS R; LLOYD C; MARESH K; MATTHEW C; MINOR S; ROBERTS R; SALMON A; SHACKELFORD P; STEWART R; THOMPSON M; YOUNG J; GUINN A; HARRIS G; HEIBIG J; LEVY VV; FORRESTER J; HICKEY A; BUCHBINDER N; DAVIDSON R; DRURY K; EBER L; EIGLER N; GEFT I; GOLDBERG S; GRODAN P; HENDEL J; HIGGINS S; HODGSON T; HUGHES L; KARLSBERG R; KATZ J; LEPOR N; LITVAK F; LUPTAK Y; MADERA G; MARCUS H; MONDKAR A; NEIDORF B; NEUMANN M; NIVATPUMIN T; RABINOWITZ Y; RAYMOND M; READER A; RURYCZ V; SCHAPIRA J; SCHLANGER J; SILVERBERG R; SMITH A; TABAK S; VALOVIS R; GRAY R; HOOGWERF B; STEWART W; BAERVEDT G; BOTTSILVERMAN C; BREEN C; BUCKNER P; CABRAL J; CRESSMAN M; FONSECA C; FOSTER J; FOSTER R; GUTMAN F; HARRIS L; HEUPLER F; HOBBS R; HUANG S; KALENAK J; KASSEM M; KOSMORSKY G; KRAMER J; KURZAWA C; LANGSTON R; LINCOFF M; LINDBERG J; LOWDER C; MCCAFFERTY F; MCKEOWN D; MEISLER D; MENDLOVIC D; MEYERS S; MOORE J; NOUSEK J; RAYMOND R; RINCON G; ROBIN J; ROCKWOOD E; SHELDON W; SIMPFENDORFER C; WALSH H; WANESS A; WRIGHT K; YANAK F; GOULET C; BEDARD H; BOIS M; BUJOLD S; COTE G; DAVIGNON J; DEBELDER M; DUCHARME AM; DOUCET S; DUMAS J; DYDRA I; FOUCHER S; CREPEAU J; GOSSELIN G; GROULX D; JOYAL M; JUNEAU M; LESPERANCE J; LEVESQUE C; LEVESQUE J; MARCIL M; OLIVIER M; PASTERNAC A; POITRAS AM; POITRAS D; QUEVILLON A; RIOUX C; ROBITAILLE D; SISOUPHONE K; SOLYMOSS C; HUNNINGHAKE D; CHRISTIANSON B; DIANGELIS N; GARDNER K; HELGREN R; IACARELLA C; KNOBLOCH W; LAU L; LAXSON D; LEON A; LONDON E; MANION R; MCDONALD K; MCGINN A; MIANULLI M; ROBINSON J; TURNER G; WANG Y; WHITE C; WILSON R; ZIMMER S; GOBEL F; ANDERSON P; BAUMGARD C; CHRISTENSEN J; FULCO A; HANSON K; JOHNSON C; LARSON B; MADISON J; MCCORMACK P; OSTROV C; PECHA R; PEDERSON W; PIER T; RANDALL M; RODMAN W; ROELLER S; SCOTT K; SHER N; SPEILMAN J; THOMPSON R; ZUPFER S; GOLDENBERG I; HEALY B; KNATTERUD G; TERRIN M; CANNER M; FICK S; FORMAN S; HANSON D; HOWARD J; HUANG AL; KARABELAS S; LOPRESTI F; MERCER W; RA K; RANDALL A; SCHACTMAN M; SCHLEIGH B; SNIDER R; MIRENZI E; FISHER M; FOX NL; CZAJKOWSKI S; GELLER N; PROBSTFIELD J; SHUMAKER S; WITTES J; YUSUF S; ZUCKER D; CARTLAND J; DAS G; MEYER S; POWERS T; RINGDAL D; ROSZA Z; SHAHEEN B; SIREK M; STONE C; SNIDER J; VANYI J; ALAUPOVIC P; FESMIRE J; WALENGA J; BERMES E; HOPPENSTEADT D; PIFARRE R; CARLETON R; BAILEY K; BRODY B; CAIRNS J; FURBERG C; FUSTER V; GRONDIN C; JENKINS D; LAROSA J; MEIER P
      THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS

      The New England journal of medicine
    45. CAMPEAU L; KNATTERUD GL; DOMANSKI M; HUNNINGHAKE DB
      PREVENTION OF ATHEROSCLEROSIS IN CORONARY-ARTERY BYPASS GRAFTS - REPLY

      The New England journal of medicine
    46. OLSON BH; ANDERSON SM; BECKER MP; ANDERSON JW; HUNNINGHAKE DB; JENKINS DJA; LAROSA JC; RIPPE JM; ROBERTS DCK; STOY DB; SUMMERBELL CD; TRUSWELL AS; WOLEVER TMS; MORRIS DH; FULGONI VL
      PSYLLIUM-ENRICHED CEREALS LOWER BLOOD TOTAL CHOLESTEROL AND LDL CHOLESTEROL, BUT NOT HDL CHOLESTEROL, IN HYPERCHOLESTEROLEMIC ADULTS - RESULTS EF A METAANALYSIS

      The Journal of nutrition
    47. HUNNINGHAKE DB
      TARGETING HIGH-RISK PATIENTS WITH HYPERCHOLESTEROLEMIA - THE EFFICACYAND SAFETY OF SIMVASTATIN 80 MG D/

      Atherosclerosis
    48. BYINGTON RP; MILLER ME; HERRINGTON D; RILEY W; PITT B; FURBERG CD; HUNNINGHAKE DB; MANCINI GBJ
      RATIONALE, DESIGN, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE RANDOMIZED EVALUATION OF THE VASCULAR EFFECTS OF NORVASC TRIAL (PREVENT)

      The American journal of cardiology
    49. DAVIDSON MH; STEIN EA; DUJOVNE CA; HUNNINGHAKE DB; WEISS SR; KNOPP RH; ILLINGWORTH DR; MITCHEL YB; MELINO MR; ZUPKIS RV; DOBRINSKA MR; AMIN RD; TOBERT JA
      THE EFFICACY AND 6-WEEK TOLERABILITY OF SIMVASTATIN 80 AND 160 MG DAY/

      The American journal of cardiology
    50. SANTANELLO NC; BARBER BL; APPLEGATE WB; ELAM J; CURTIS C; HUNNINGHAKE DB; GORDON DJ
      EFFECT OF PHARMACOLOGICAL LIPID-LOWERING ON HEALTH-RELATED QUALITY-OF-LIFE IN OLDER PERSONS - RESULTS FROM THE CHOLESTEROL REDUCTION IN SENIORS PROGRAM (CRISP) PILOT-STUDY

      Journal of the American Geriatrics Society
    51. FORRESTER JS; MERZ CNB; BUSH TL; COHN JN; HUNNINGHAKE DB; PARTHASARATHY S; SUPERKO HR
      TASK-FORCE 4 - EFFICACY OF RISK FACTOR MANAGEMENT

      Journal of the American College of Cardiology
    52. CHESNEY CM; HERD JA; ELAM MB; GARG R; DAVIS KB; KENNEDY JW; HUNNINGHAKE DB; APPLEGATE WB
      NIACIN LOWERS FIBRINOGEN IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)

      Circulation
    53. ELAM MB; SMITH MD; YOUNG MZ; GRANEY MJ; CHESNEY CM; GARG R; EGAN DA; PETTINGER MB; DAVIS KB; HUNNINGHAKE DB; CROUSE JR; HERD JA; KOSTIS JB; SHEPS DS; APPLEGATE WB
      CORRELATION OF RISK-FACTORS WITH SEVERITY OF LOWER-EXTREMITY VASCULAR-DISEASE IN THE ATHEROSCLEROTIC DISEASE MULTIPLE INTERVENTION TRIAL (ADMIT) - INFLUENCE OF SEX AND RACE

      Circulation
    54. BROYLES FE; WALDEN CE; HUNNINGHAKE DB; HILLWILLIAMS D; KNOPP RH
      EFFECT OF FLUVASTATIN ON INTERMEDIATE DENSITY LIPOPROTEIN (REMNANTS) AND OTHER LIPOPROTEIN LEVELS IN HYPERCHOLESTEROLEMIA

      The American journal of cardiology
    55. SHARMA AK; MYERS TA; HUNNINGHAKE DB; MATAS AJ; KASHTAN CE
      HYPERLIPIDEMIA IN LONG-TERM SURVIVORS OF PEDIATRIC RENAL-TRANSPLANTATION

      Clinical transplantation
    56. HUNNINGHAKE DB
      DIAGNOSIS AND TREATMENT OF LIPID DISORDERS

      The Medical clinics of North America
    57. HUNNINGHAKE DB
      LIPID DISORDERS - PREFACE

      The Medical clinics of North America
    58. YUAN JN; TSAI MY; HUNNINGHAKE DB
      CHANGES IN COMPOSITION AND DISTRIBUTION OF LDL SUBSPECIES IN HYPERTRIGLYCERIDEMIC AND HYPERCHOLESTEROLEMIC PATIENTS DURING GEMFIBROZIL THERAPY

      Atherosclerosis
    59. FURBERG CD; ADAMS HP; APPLEGATE WB; BYINGTON RP; ESPELAND MA; HARTWELL T; HUNNINGHAKE DB; LEFKOWITZ DS; PROBSTFIELD J; RILEY WA; YOUNG B
      EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS

      Circulation
    60. LAROSA JC; APPLEGATE W; CROUSE JR; HUNNINGHAKE DB; GRIMM R; KNOPP R; ECKFELDT JH; DAVIS CE; GORDON DJ
      CHOLESTEROL-LOWERING IN THE ELDERLY - RESULTS OF THE CHOLESTEROL REDUCTION IN SENIORS PROGRAM (CRISP) PILOT-STUDY

      Archives of internal medicine
    61. PROBSTFIELD JL; HUNNINGHAKE DB
      NICOTINIC-ACID AS A LIPOPROTEIN-ALTERING AGENT - THERAPY DIRECTED BY THE PRIMARY PHYSICIAN

      Archives of internal medicine
    62. HUNNINGHAKE DB; MILLER VT; LAROSA JC; KINOSIAN B; JACOBSON T; EDELMAN DA; OCONNOR RR; BROWN V; HOWARD WJ
      LONG-TERM TREATMENT OF HYPERCHOLESTEROLEMIA WITH DIETARY FIBER

      The American journal of medicine
    63. HUNNINGHAKE DB; MILLER VT; LAROSA JC; KINOSIAN B; BROWN V; HOWARD WJ; DISERIO FJ; OCONNOR RR
      HYPOCHOLESTEROLEMIC EFFECTS OF A DIETARY FIBER SUPPLEMENT

      The American journal of clinical nutrition
    64. QUITER ES; HUEBSCH JA; ADMIRE JA; HOLTAN NR; HUNNINGHAKE DB
      DEVELOPMENT OF A DIET ASSESSMENT-TOOL FOR SOUTHEAST-ASIAN IMMIGRANTS

      The American journal of clinical nutrition
    65. PETERS JR; QUITER ES; BREKKE ML; ADMIRE J; BREKKE MJ; MULLIS RM; HUNNINGHAKE DB
      THE EATING PATTERN ASSESSMENT-TOOL - A SIMPLE INSTRUMENT FOR ASSESSING DIETARY-FAT AND CHOLESTEROL INTAKE

      Journal of the American Dietetic Association
    66. HUNNINGHAKE DB
      WHICH PATIENTS NEED AGGRESSIVE LIPID-ALTERING THERAPY

      Cleveland Clinic journal of medicine
    67. WALENGA JM; PIFARRE R; CRESSMAN MD; HUNNINGHAKE DB; FOX NL; PROBSTFIELD JL
      HEMOSTATIC CHARACTERISTICS OF POST CABG PATIENTS AND THE EFFECTS OF 1-MG WARFARIN

      Thrombosis and haemostasis
    68. GRUNDY SM; BILHEIMER D; CHAIT A; CLARK LT; DENKE M; HAVEL RJ; HAZZARD WR; HULLEY SB; HUNNINGHAKE DB; KREISBERG RA; KRISETHERTON P; MCKENNEY JM; NEWMAN MA; SCHAEFER EJ; SOBEL BE; SOMELOFSKI C; WEINSTEIN MC; BREWER HB; CLEEMAN JI; DONATO KA; ERNST N; HOEG JM; RIFKIND BM; ROSSOUW J; SEMPOS CT; GALLIVAN JM; HARRIS MN; QUINTADLER L
      SUMMARY OF THE 2ND REPORT OF THE NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) EXPERT PANEL ON DETECTION, EVALUATION, AND TREATMENT OF HIGHBLOOD CHOLESTEROL IN ADULTS (ADULT-TREATMENT-PANEL-II)

      JAMA, the journal of the American Medical Association
    69. HUNNINGHAKE DB; STEIN EA; MELLIES MJ
      EFFECTS OF ONE-YEAR OF TREATMENT WITH PRAVASTATIN, AN HMG-COA REDUCTASE INHIBITOR, ON LIPOPROTEIN-A

      Journal of clinical pharmacology
    70. WINCHELL GA; GREGOIRE S; TAYLOR AM; HEGLAND J; HUNNINGHAKE DB
      FINASTERIDE, A STEROID 5-ALPHA-REDUCTASE INHIBITOR, DOES NOT AFFECT THE OXIDATIVE-METABOLISM OF ANTIPYRINE

      Journal of clinical pharmacology
    71. HALPIN RA; ULM EH; TILL AE; KARI PH; VYAS KP; HUNNINGHAKE DB; DUGGAN DE
      BIOTRANSFORMATION OF LOVASTATIN .5. SPECIES-DIFFERENCES IN IN-VIVO METABOLITE PROFILES OF MOUSE, RAT, DOG, AND HUMAN

      Drug metabolism and disposition
    72. HUNNINGHAKE DB
      TREATMENT OF AND SCREENING FOR HYPERLIPIDEMIA - REPLY

      The New England journal of medicine
    73. HUNNINGHAKE DB; STEIN EA; DUJOVNE CA; HARRIS WS; FELDMAN EB; MILLER VT; TOBERT JA; LASKARZEWSKI PM; QUITER E; HELD J; TAYLOR AM; HOPPER S; LEONARD SB; BREWER BK
      THE EFFICACY OF INTENSIVE DIETARY THERAPY ALONE OR COMBINED WITH LOVASTATIN IN OUTPATIENTS WITH HYPERCHOLESTEROLEMIA

      The New England journal of medicine
    74. KNOPP RH; BROWN WV; CORDER CN; DOBS AS; DUJOVNE CA; GOLDBERG AC; HUNNINGHAKE DB; INSULL W; MELLIES MJ; SMITH DA; STEIN EA
      COMPARATIVE EFFICACY AND SAFETY OF PRAVASTATIN AND CHOLESTYRAMINE ALONE AND COMBINED IN PATIENTS WITH HYPERCHOLESTEROLEMIA

      Archives of internal medicine
    75. DUJOVNE CA; EFF J; FERRARO L; GOLDSTEIN RJ; GOTTO AM; HALL WD; HARRIS WS; HELD SJ; HERD A; HUNNINGHAKE DB; JOHNSON BF; SZTERN MI
      COMPARATIVE EFFECTS OF ATENOLOL VERSUS CELIPROLOL ON SERUM-LIPIDS ANDBLOOD-PRESSURE IN HYPERLIPIDEMIC AND HYPERTENSIVE SUBJECTS

      The American journal of cardiology
    76. PETERS JR; KUBO SH; OLIVARI MT; KNUTSON KR; HUNNINGHAKE DB
      TREATMENT OF HYPERLIPIDEMIA IN HEART-TRANSPLANT RECIPIENTS WITH GEMFIBROZIL + - LOVASTATIN/

      The American journal of cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 03:48:47